Research on LncRNA CTBP1-DT As a Potential Therapeutic Target to Regulate Cell Function in Colorectal Cancer

Overview

Journal Discov Oncol

Publisher Springer

Specialty Oncology

Date 2024 Jun 12

PMID 38864997

Authors

Ruizhi Fan

Teng Xu

Yuting Kuang

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer, which originates from the human colon or rectum, is one of the leading causes of death worldwide. Timely diagnosis and interventional therapy can significantly improve the prognostic survival of colorectal cancer patients, making regular screening and early detection essential.

Aim: To investigate the regulatory function of lncRNA CTBP1-DT (CTBP1-DT) on colorectal cancer cells and to assess its diagnostic significance.

Methods: A total of 102 patients with colorectal cancer and 92 healthy individuals were selected. The levels of CTBP1-DT and microRNA-30a-5p (miR-30a-5p) in serum and cell samples of the above subjects were compared by RT-qPCR. The effects of CTBP1-DT and miR-30a-5p dysregulation on the biological functions of colorectal cancer cells were analyzed via CCK-8, flow cytometry and Transwell assays. In addition, the ability of CTBP1-DT and miR-30a-5p to early identify colorectal cancer patients was determined through ROC curve.

Results: Serum CTBP1-DT was elevated in patients with colorectal cancer, which was obviously higher than in healthy controls. The expression of serum miR-30a-5p was downregulated in colorectal cancer. Both CTBP1-DT and miR-30a-5p have the value of distinguishing colorectal cancer, and the combined diagnostic ability is higher. Knockdown of CTBP1-DT directly targeted miR-30a-5p to repress cell activity and metastatic ability, whereas deregulation of miR-30a-5p eliminated the above inhibitory effects.

Conclusion: Overexpression of CTBP1-DT has a certain application potential in the diagnosis of colorectal cancer and may be a therapeutic target for colorectal cancer.

References

Tang M, Zhou J, You L, Cui Z, Zhang H . LIN28B/IRS1 axis is targeted by miR-30a-5p and promotes tumor growth in colorectal cancer. J Cell Biochem. 2019; 121(8-9):3720-3729. DOI: 10.1002/jcb.29529. View

Lin X, Zhuang S, Chen X, Du J, Zhong L, Ding J . lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling. Mol Ther. 2021; 30(2):688-702. PMC: 8821934. DOI: 10.1016/j.ymthe.2021.08.011. View

Hajibabaie F, Abedpoor N, Mohamadynejad P . Types of Cell Death from a Molecular Perspective. Biology (Basel). 2023; 12(11). PMC: 10669395. DOI: 10.3390/biology12111426. View

Xian D, Niu L, Zeng J, Wang L . LncRNA KCNQ1OT1 Secreted by Tumor Cell-Derived Exosomes Mediates Immune Escape in Colorectal Cancer by Regulating PD-L1 Ubiquitination MiR-30a-5p/USP22. Front Cell Dev Biol. 2021; 9:653808. PMC: 8326752. DOI: 10.3389/fcell.2021.653808. View

Guo M, Zhang X . LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2. World J Surg Oncol. 2022; 20(1):95. PMC: 8961944. DOI: 10.1186/s12957-022-02567-5. View

Zeng F, You S, Dai X . MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45. Histol Histopathol. 2022; 37(5):483-492. DOI: 10.14670/HH-18-424. View

Wang H, Wei Z, Li J, Feng S . Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury. Neural Regen Res. 2021; 17(5):963-971. PMC: 8552873. DOI: 10.4103/1673-5374.324823. View

Maldonado H, Leyton L . CSK-mediated signalling by integrins in cancer. Front Cell Dev Biol. 2023; 11:1214787. PMC: 10382208. DOI: 10.3389/fcell.2023.1214787. View

Chen M, Tong C, Wu Q, Zhong Z, He Q, Zeng L . 6-Shogaol Inhibits the Cell Migration of Colon Cancer by Suppressing the EMT Process Through the IKKβ/NF-κB/Snail Pathway. Integr Cancer Ther. 2023; 22:15347354231172732. PMC: 10185977. DOI: 10.1177/15347354231172732. View

10.

Li R, Guan M, Zhou Z, Dong S, Liu Q . The Role of circRNAs in the Diagnosis of Colorectal Cancer: A Meta-Analysis. Front Med (Lausanne). 2021; 8:766208. PMC: 8641696. DOI: 10.3389/fmed.2021.766208. View

11.

Wang X, Meng Q, Chen Y, Zhang Y, Huang X, Xiang L . Prognostic immunogenic characteristics of iron pendant disease modifiers in colon cancer. Front Immunol. 2023; 14:1100725. PMC: 10251496. DOI: 10.3389/fimmu.2023.1100725. View

12.

Kaviani E, Hajibabaie F, Abedpoor N, Safavi K, Ahmadi Z, Karimy A . System biology analysis to develop diagnostic biomarkers, monitoring pathological indexes, and novel therapeutic approaches for immune targeting based on maggot bioactive compounds and polyphenolic cocktails in mice with gastric cancer. Environ Res. 2023; 238(Pt 2):117168. DOI: 10.1016/j.envres.2023.117168. View

13.

Guo S, Chen M, Li S, Geng Z, Jin Y, Liu D . Natural Products Treat Colorectal Cancer by Regulating miRNA. Pharmaceuticals (Basel). 2023; 16(8). PMC: 10459054. DOI: 10.3390/ph16081122. View

14.

Bevacqua E, Ammirato S, Cione E, Curcio R, Dolce V, Tucci P . The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a Machine Learning Approach. Cancers (Basel). 2022; 14(21). PMC: 9657574. DOI: 10.3390/cancers14215418. View

15.

Fang J, Jiang G, Mao W, Huang L, Huang C, Wang S . Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis. Bioengineered. 2022; 13(2):3707-3723. PMC: 8973591. DOI: 10.1080/21655979.2022.2026728. View

16.

Olatubosun M, Abubakar M, El-Saber Batiha G, Malami I, Ibrahim K, Abubakar B . LncRNA SNHG15: A potential therapeutic target in the treatment of colorectal cancer. Chem Biol Drug Des. 2022; 101(5):1138-1150. DOI: 10.1111/cbdd.14036. View

17.

Yu R, Hu Y, Zhang S, Li X, Tang M, Yang M . LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms. Nucleic Acids Res. 2022; 50(14):8060-8079. PMC: 9371908. DOI: 10.1093/nar/gkac611. View

18.

Cheng C, Yang B, Chen W, Ho A, Sie Z, Lin H . STAT3 Mediated miR-30a-5p Inhibition Enhances Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells. Int J Mol Sci. 2020; 21(19). PMC: 7583989. DOI: 10.3390/ijms21197315. View

19.

Sun Y, Yang B, Lin M, Yu H, Chen H, Zhang Z . Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer. Cancer Biomark. 2019; 24(3):299-305. DOI: 10.3233/CBM-182129. View

20.

Lu R, Li Z, Yin S . Constructing a Ferroptosis-related Long Non-coding RNA Signature to Predict the Prognostic of Head and Neck Squamous Cell Carcinoma Patients by Bioinformatic Analysis. Biochem Genet. 2022; 60(5):1825-1844. PMC: 9470613. DOI: 10.1007/s10528-021-10176-2. View